| |
|
|
|
Entera Bio Ltd  
|
|
1.5 0.06 (0.04%) |
01-28 09:50 |
|
Open: |
1.42 |
Pre close: |
1.44 |
Target:
|
2.13
|
|
High: |
1.51 |
Low: |
1.42 |
Resistance:
|
1.82
2.13
|
|
Volume: |
40,676 |
Market Cap: |
32M |
Support:
|
1.33
1.03
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.62
 |
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
1.33  |
Signal(12,26,9): |
0.10 |
|
MA(100): |
1.17 |
Stochastic Oscillator |
%K(14,3):
|
61.12 |
|
MA(250): |
1.75 |
%D(3): |
72.67 |
|
Average Volume(K) |
3-Month: |
57409
|
52-Week |
High:
|
3.40 |
|
10-Days: |
66118 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
56.25 |
Change(%): |
-53.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.658 |
Return on Equity (ttm) |
-228.5 |
Shares Out. (M) |
18.36 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-98.2 |
Shares Float (M) |
8.98 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.19 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-16.7 |
% Held by Institutions |
10.38 |
|
Forward EPS |
1.310 |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
49 |
|
Book Value (p.s.) |
0.310 |
EBITDA (p.s.) |
-0.685 |
P/E |
-2.19 |
|
Sales Per Share |
0.013 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.65 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.23 |
P/S |
107.47 |
|
Operating Margin |
-5141.06 |
Levered Free Cash Flow
(M) |
-6.33 |
P/CF |
-2.16 |
|
|
|
|
|
|
